A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
Phase 1
Recruiting
- Conditions
- Breast CancerCancer of BreastCancer of the BreastTumors, BreastBreast TumorMalignant Tumor of Breast
- Interventions
- Biological: Bria-OTS regimen and CPI (tislelizumab) expansion cohortBiological: BC1 cell lineBiological: Bria-OTS regimen and CPI (tislelizumab)
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- BriaCell Therapeutics Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT06471673
- Locations
- 🇺🇸
Sarcoma Oncology Center, Santa Monica, California, United States
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Phase 3
Recruiting
- Conditions
- Metastatic Breast CancerBreast NeoplasmEnd Stage CancerBreast CancerBreast Cancer Metastatic
- Interventions
- Drug: Treatment of Physician's ChoiceDrug: Interferon infiltration of the inoculation site
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- BriaCell Therapeutics Corporation
- Target Recruit Count
- 404
- Registration Number
- NCT06072612
- Locations
- 🇺🇸
Los Angeles cancer Network_Anaheim, Anaheim, California, United States
🇺🇸Los Angeles Cancer Network_Corona, Corona, California, United States
🇺🇸Los Angeles cancer Network_Fountain Vallley, Fountain Valley, California, United States
Combination Study of SV-BR-1-GM With Retifanlimab
Phase 1
- Conditions
- Breast CancerBreast Cancer MetastaticBreast NeoplasmMetastatic Breast Cancer
- Interventions
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- BriaCell Therapeutics Corporation
- Target Recruit Count
- 36
- Registration Number
- NCT03328026
- Locations
- 🇺🇸
Nebraska Cancer Specialists, Omaha, Nebraska, United States
🇺🇸St. Joseph Heritage Healthcare, Santa Rosa, California, United States
🇺🇸St Vincent-Frontier Cancer Center, Billings, Montana, United States
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
Phase 1
Completed
- Conditions
- BreastcancerBreast Neoplasm
- Interventions
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- BriaCell Therapeutics Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT03066947
- Locations
- 🇺🇸
St. Joseph Heritage Healthcare, Santa Rosa, California, United States
🇺🇸University of Miami/Sylvester at Plantation, Plantation, Florida, United States
🇺🇸Cancer Center of Kansas (CCK), Wichita, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath